GlassScriptPhysician profile
Joe S Robinson
NPI 1225075815
$948.86
in general payments reported to CMS, 2019-2025
21 companies · $30.81 in 2025
The $30.81 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $116 · 2021: $210 · 2022: $104 · 2023: $106 · 2024: $107 · 2025: $30.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $268.14 | 2019-2020 | |
| Baxter Healthcare | $105.17 | 2021-2025 | Floseal |
| Integra Lifesciences Corporation | $88.71 | 2021 | |
| Djo, LLC | $76.74 | 2021-2024 | Cmf |
| Lemaitre Vascular, INC. | $62.08 | 2022-2024 | Anastoclip Gc 8cm (Medium) |
| Stryker Corporation | $59.76 | 2021-2024 | Spinejack |
| Nevro Corp. | $58.61 | 2019 | |
| Samsung Hme America, INC. | $50.00 | 2022 | |
| Brainlab, INC. | $26.43 | 2021-2025 | Brainlab, INC. |
| Sk Life Science, INC. | $22.67 | 2021 | |
| Boston Scientific Corporation | $20.84 | 2024 | Wavewriter Alpha Prime 16 |
| Csl Behring | $16.70 | 2021 | |
| Elutia, INC. | $15.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.64 | 2023 | Andexxa |
| Si-Bone, INC. | $13.81 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $13.69 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.50 | 2022 | |
| Irras USA, INC. | $13.11 | 2020 | |
| Cerapedics INC. | $8.59 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$594,323.82 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.